Jeff Garro
Stock Analyst at Stephens & Co.
(1.77)
# 3,760
Out of 5,099 analysts
56
Total ratings
36.84%
Success rate
-9.99%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $24.18 | +32.34% | 6 | Dec 4, 2025 | |
| OPRX OptimizeRx | Maintains: Equal-Weight | $20 → $17 | $13.87 | +22.57% | 4 | Nov 17, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $3.88 | +131.96% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $15.78 | +102.79% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $19.80 | +1.01% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $22.38 | +25.11% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $229.16 | +22.19% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $2.64 | +89.39% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $9.28 | +83.19% | 5 | Feb 27, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $2.38 | +110.08% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $55 | $45.04 | +22.11% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $222.92 | +12.15% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $22.03 | -22.83% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $7.69 | +264.11% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $18.91 | +5.76% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $5.15 | -24.27% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $1.39 | +115.83% | 3 | May 6, 2022 |
Privia Health Group
Dec 4, 2025
Reiterates: Overweight
Price Target: $32
Current: $24.18
Upside: +32.34%
OptimizeRx
Nov 17, 2025
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $13.87
Upside: +22.57%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $3.88
Upside: +131.96%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $15.78
Upside: +102.79%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $19.80
Upside: +1.01%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $22.38
Upside: +25.11%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $229.16
Upside: +22.19%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.64
Upside: +89.39%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $9.28
Upside: +83.19%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $2.38
Upside: +110.08%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $45.04
Upside: +22.11%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $222.92
Upside: +12.15%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $22.03
Upside: -22.83%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $7.69
Upside: +264.11%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $18.91
Upside: +5.76%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $5.15
Upside: -24.27%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $1.39
Upside: +115.83%